These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6286777)

  • 21. Development of cholecystokinin radioimmunoassay using synthetic CCK-10 as immunogen.
    Turkelson CM; Dale WE; Reidelberger R; Solomon TE
    Regul Pept; 1986 Oct; 15(3):205-17. PubMed ID: 3786838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunoassay of plasma cholecystokinin (CCK), duodenal release of CCK, diurnal variation of plasma CCK, and immunoreactive plasma CCK components in man.
    Burhol PG; Rayford PL; Jorde R; Waldum HL; Schulz TB; Thompson JC
    Hepatogastroenterology; 1980 Aug; 27(4):300-9. PubMed ID: 7193631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of central cholecystokinin receptors using a radioiodinated octapeptide probe.
    Wennogle LP; Steel DJ; Petrack B
    Life Sci; 1985 Apr; 36(15):1485-92. PubMed ID: 2984502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding sites for 125I-cholecystokinin in primate spinal cord are of the CCK-A subclass.
    Hill DR; Shaw TM; Woodruff GN
    Neurosci Lett; 1988 Jun; 89(2):133-9. PubMed ID: 3134624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct cholecystokinin receptors in brain and pancreas.
    Innis RB; Snyder SH
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6917-21. PubMed ID: 6256771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma cholecystokinin concentrations in patients with pancreatic insufficiency measured by sequence-specific radioimmunoassays.
    Jansen JB; Hopman WP; Lamers CB
    Dig Dis Sci; 1984 Dec; 29(12):1109-17. PubMed ID: 6499629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity.
    Makovec F; Bani M; Chisté R; Revel L; Rovati LC; Rovati LA
    Arzneimittelforschung; 1986; 36(1):98-102. PubMed ID: 3006713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of cholecystokinin receptor binding to regulation of biological functions in pancreatic acini.
    Sankaran H; Goldfine ID; Bailey A; Licko V; Williams JA
    Am J Physiol; 1982 Mar; 242(3):G250-7. PubMed ID: 6175228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin and gastrin are not equally sensitive to GTP gamma S at CCKB receptors: importance of the sulphated tyrosine.
    Lallement JC; Oiry C; Lima-Leite AC; Lignon MF; Fulcrand P; Galleyrand JC; Martinez J
    Eur J Pharmacol; 1995 Jul; 290(2):61-7. PubMed ID: 8575534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunoassay of cholecystokinin in human plasma.
    Byrnes DJ; Henderson L; Borody T; Rehfeld JF
    Clin Chim Acta; 1981 Mar; 111(1):81-9. PubMed ID: 7194753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.
    Murphy RB
    Prog Clin Biol Res; 1985; 192():105-13. PubMed ID: 3001746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The CCK receptor on pancreatic plasma membranes: binding characteristics and covalent cross-linking.
    Sakamoto C; Williams JA; Wong KY; Goldfine ID
    FEBS Lett; 1983 Jan; 151(1):63-6. PubMed ID: 6297990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accurate measurement of cholecystokinin in plasma.
    Rehfeld JF
    Clin Chem; 1998 May; 44(5):991-1001. PubMed ID: 9590372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity of cholecystokinin antibody may influence choice of tracer for radioimmunoassay.
    Murphy RF; Balasubramaniam A; Chen MH; Cardin AD; Rayford PL; Jackson RL; Joffe SN
    J Immunol Methods; 1984 Nov; 74(1):199-203. PubMed ID: 6501886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches.
    Moran TH; Smith GP; Hostetler AM; McHugh PR
    Brain Res; 1987 Jul; 415(1):149-52. PubMed ID: 2441809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iodination with Iodo-gen and radioimmunoassay of cholecystokinin (CCK) in acidified plasma, CCK release, and molecular CCK components in man.
    Burhol PG; Jenssen TG; Lygren I; Schulz TB; Jorde R; Waldum HL
    Digestion; 1982; 23(3):156-68. PubMed ID: 7106417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP; Zhou W; Longnecker DS; Bell RH
    Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new probe for affinity labelling pancreatic cholecystokinin receptor with minor modification of its structure.
    Fourmy D; Lopez P; Poirot S; Jimenez J; Dufresne M; Moroder L; Powers SP; Vaysse N
    Eur J Biochem; 1989 Nov; 185(2):397-403. PubMed ID: 2583188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors.
    Schäfer U; Harhammer R; Boomgaarden M; Sohr R; Ott T; Henklein P; Repke H
    J Neurochem; 1994 Apr; 62(4):1426-31. PubMed ID: 8133271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
    Corp ES; McQuade J; Moran TH; Smith GP
    Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.